Targeting the link between ovarian cancer [145], esophageal squamous cell carcinoma [90], and other cancers with AGR2 immunity, we can hypothesize that AGR2 influences the immune microenvironment of patients, suggesting a potential undiscovered link between the two that may impact patient prognosis. The gene discussed is AGR2; the disease is ovarian carcinoma.